ArticleLife (Basel, Switzerland)2026
Network Pharmacology and Molecular Docking-Based Investigation of Empagliflozin's Therapeutic Potential in Chronic Kidney Disease.
Aman Tedasen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.